In a discovery that reframes how scientists understand one of the most common causes of nephrotic syndrome, researchers have shown that podocytes—the delicate filtration cells of the kidney—are not merely passive victims of immune attack but active instigators of it. A new study published in the Journal of Advanced Research demonstrates that injured podocytes package antigen-presenting machinery into tiny membrane-bound vesicles called exosomes, which then travel through the circulation and instruct the immune system to escalate its assault on the kidney. The findings offer a long-sought explanation for the puzzling systemic inflammation seen in minimal change disease, a condition in which the kidney’s filtering units leak massive amounts of protein even though immune cells are conspicuously absent from the damaged tissue itself.
Minimal change disease is defined by an abrupt onset of heavy proteinuria, low blood albumin, and elevated blood lipids. Under the electron microscope, the hallmark is the diffuse effacement of podocyte foot processes, the interdigitating projections that anchor these cells to the glomerular basement membrane and dynamically regulate filtration permeability. Yet light microscopy typically reveals an unremarkable glomerular architecture, and renal biopsies from many patients show no significant infiltration of T cells. This paradox has haunted nephrologists for decades: aberrant T cell activation is clearly implicated in driving podocyte injury, but the mechanism by which T cells are mobilized without ever visibly entering the kidney has remained elusive. Compounding the clinical problem, roughly twenty to thirty percent of adult patients develop steroid dependence or resistance, and some progress to end-stage renal disease.
The research team, led by investigators at Nanjing University Medical School and collaborating institutions, approached the problem by integrating clinical analysis with in vitro and in vivo experimental models. Their central hypothesis centered on extracellular vesicles—lipid bilayer-enclosed nanoscale particles that shuttle proteins, lipids, nucleic acids, and metabolites between cells. Exosomes, the smallest of these vesicles at thirty to one hundred fifty nanometers, have previously been found at elevated levels in the urine of patients with metabolic syndrome-associated kidney disease, renovascular hypertension, and preeclampsia, with their abundance correlating with proteinuria severity. What remained undefined was whether podocyte-derived exosomes could actually mediate communication between podocytes and T cells through antigen presentation.
In laboratory experiments, the researchers cultured mouse podocytes with a model antigen and interferon-gamma, an inflammatory cytokine. When naive T cells from OT-I transgenic mice—whose receptors specifically recognize the model antigen—were co-cultured with these activated podocytes, flow cytometry revealed a striking upregulation of the activation markers CD69 and CD25. Critically, adding GW4869, an inhibitor of exosome secretion, abolished this activation, indicating that the podocytes were stimulating T cells through released exosomes rather than direct contact. Characterization of the isolated vesicles confirmed their exosomal identity: they carried the canonical markers TSG101, ALIX, and CD63 but lacked the negative control protein calnexin, displayed a characteristic cup-shaped morphology under transmission electron microscopy, and measured fifty to one hundred fifty nanometers in diameter.
The mechanistic crux of the study lies in major histocompatibility complex class I molecules. Interferon-gamma stimulation significantly increased the expression of MHC-I, MHC-II, and the costimulatory molecules CD80 and CD86 on podocyte-derived exosomes. When the researchers generated podocytes deficient in MHC-I through lentiviral knockdown, exosomes from these cells completely failed to activate T cells. In vivo, the team depleted professional antigen-presenting cells by whole-body irradiation and then injected MHC-I-deficient exosomes alongside OT-I CD8-positive T cells into mice with puromycin aminonucleoside-induced minimal change disease. These mice exhibited significantly lower urinary protein-to-creatinine ratios and markedly fewer activated interferon-gamma-positive T cells in renal lymph nodes and spleen compared with controls receiving intact exosomes. The conclusion was unambiguous: CD8-positive T cell activation by podocyte exosomes is strictly dependent on MHC-I-mediated antigen presentation.
Perhaps the most elegant finding concerns the division of labor between podocyte exosomes and dendritic cells. While exosomes alone could trigger T cell activation, they could not drive T cell proliferation without dendritic cells present. In irradiated mice lacking dendritic cells, podocyte exosomes still activated kidney-resident memory T cells and worsened proteinuria, but systemic T cell expansion was blunted. When the researchers reconstituted dendritic cells by bone marrow-derived cell transfer, the full pathological cascade returned. This suggests a biphasic mechanism the authors describe as local activation followed by systemic amplification: exosomes mediate antigen presentation to tissue-resident memory T cells within the kidney to ignite early inflammation, while dendritic cells relay antigenic signals to secondary lymphoid organs, where they recruit and expand effector T cell populations. The data favor a reprocessing model in which dendritic cells internalize exosomes, degrade their cargo, and load peptides onto their own MHC-I molecules, rather than simply acquiring pre-formed complexes on their surface.
To establish clinical relevance, the team developed an autologous pairing system using samples from twenty patients with biopsy-confirmed minimal change disease and twenty with lupus nephritis. Plasma from each patient was split so that podocyte-derived exosomes, identified by the podocyte marker podocalyxin, could be isolated and paired with naive CD8-positive T cells from the same individual’s blood. Exosomes from both patient groups carried high levels of MHC-I, MHC-II, CD80, and CD86. Exposure to these autologous exosomes triggered robust T cell receptor signaling, evidenced by increased phosphorylation of ZAP-70 and Lck, followed by CD69 and CD25 upregulation, substantial proliferation by seventy-two hours, and elevated interferon-gamma secretion. Mass spectrometry of patient-derived exosomes identified 108 proteins unique to minimal change disease samples, including immunoglobulin variable region components and complement proteins, and bioinformatic screening against the Immune Epitope Database flagged twelve candidate autoantigens, with dermcidin prioritized on the basis of an HSP70-binding domain and an embedded HLA-A*03 epitope. Levels of exosomal MHC-I and CD80 correlated strongly with disease severity measures.
The therapeutic implications were tested through two complementary strategies. Pharmacological inhibition with GW4869 reduced renal exosome burden, lowered the urinary albumin-to-creatinine ratio, and decreased effector CD8-positive interferon-gamma-positive T cells in renal lymph nodes and spleen. More precisely, the team engineered podocyte-specific manipulation of Rab27a, a membrane-binding GTPase that governs the docking of multivesicular endosomes with the plasma membrane and thereby controls exosome release. Genetic overexpression of Rab27a in podocytes accelerated disease, while podocyte-specific knockout suppressed exosome secretion even more effectively than GW4869 and attenuated disease progression. Because GW4869 lacks tissue specificity and could disrupt beneficial exosome secretion in immune and endothelial cells, the podocyte-restricted genetic approach provides a cleaner proof of principle, pointing toward kidney-targeted nanocarrier delivery systems or CRISPR-based spatiotemporal control of Rab27a as future therapeutic avenues.
The study’s authors acknowledge that the candidate autoantigens remain at the level of computational prediction and will require direct validation through MHC-I immunopeptidomics and autologous T cell priming assays. Mouse models also cannot fully recapitulate human disease, and questions remain about whether exosomes influence B cells and macrophages as well. Nevertheless, the work fundamentally redefines podocytes as non-classical antigen-presenting cells and identifies a concrete, targetable pathway—Rab27a-dependent exosome release—linking podocyte injury to systemic T cell immunity. For a disease in which twenty to thirty percent of adult patients fail first-line steroid therapy, the prospect of intercepting these molecular messengers before they mobilize the immune system represents a compelling new frontier in precision nephrology.
Subject of Research: Podocyte-derived exosome-mediated antigen presentation and CD8-positive T cell activation in minimal change disease
Article Title: Podocyte-derived exosomes instruct dendritic cell-dependent CD8 + T cell activation and proliferation in renal inflammation
Article References: Qian, B., Mao, S., Chen, Y., Liu, Y., Zhang, M., Zhu, D., Zen, K., Wang, Y., Liu, Z., & Li, L. (2026). Podocyte-derived exosomes instruct dendritic cell-dependent CD8+ T cell activation and proliferation in renal inflammation. Journal of Advanced Research, 88, 885-898. https://doi.org/10.1016/j.jare.2026.01.032
Image Credits: AI Generated
DOI: 10.1016/j.jare.2026.01.032
Keywords: podocytes, exosomes, minimal change disease, CD8 T cells, MHC-I, dendritic cells, Rab27a, nephrotic syndrome, antigen presentation, renal inflammation, extracellular vesicles, proteinuria
Cite Scienmag News
APA
MLA
Chicago
Ophelia Keating. (October 2, 2026). Kidney Cells Caught Dispatching Exosomes That Ignite Immune Attack in Nephrotic Syndrome. Scienmag. https://scienmag.com/kidney-cells-caught-dispatching-exosomes-that-ignite-immune-attack-in-nephrotic-syndrome/
Ophelia Keating. “Kidney Cells Caught Dispatching Exosomes That Ignite Immune Attack in Nephrotic Syndrome.” Scienmag, 2 October 2026, https://scienmag.com/kidney-cells-caught-dispatching-exosomes-that-ignite-immune-attack-in-nephrotic-syndrome/. Accessed 2 October 2026.
Ophelia Keating. “Kidney Cells Caught Dispatching Exosomes That Ignite Immune Attack in Nephrotic Syndrome.” Scienmag. October 2, 2026. https://scienmag.com/kidney-cells-caught-dispatching-exosomes-that-ignite-immune-attack-in-nephrotic-syndrome/
Copy citation
Download RIS
Tags: antigen presentationCD8+ T cellsdendritic cellsexosome-mediated immune system regulation in kidney diseaseexosomesextracellular vesiclesimmune activation in nephrotic syndromeimmune system activation without T cell infiltration in nephrotic syndromekidney cell-derived exosomes and immune signalingkidney podocyte exosome communicationmechanisms of podocyte injury leadingMHC-Iminimal change diseasenephrotic syndromepathophysiology of proteinuria in minimal change diseasepodocyte antigen presentation in minimal change diseasepodocyte injury and immune system interplaypodocytesproteinuriaRAB27Arenal inflammationrole of exosomes in kidney inflammationsystemic inflammation mechanisms in nephrotic syndrome
